U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07494058) titled 'A Study of Home vs Hospital Treatment in People With Fabry, Gaucher or Hunter Conditions in Mexico' on March 20.
Brief Summary: During the COVID-19 pandemic, home treatment for conditions such as Fabry, Gaucher or Hunter became important because it is easier for people to stick to their treatment if medicines that need to be given as infusion (called intravenous or IV treatment) can be given at home or somewhere close to home. Additionally, many of the hospitals that provide infusions are centralized in Mexico.
The main aim of the study is to find out whether people with Fabry, Gaucher or Hunter condition are more likely to contin...